
Flexible and efficient methods are needed for biopharmaceutical manufacturing.

Flexible and efficient methods are needed for biopharmaceutical manufacturing.

The latest manufacturing technologies are essential for helping pharmaceutical formulators meet up-and-coming trends in OSD treatments.

By following some fundamental steps, manufacturers can optimize their tablet tooling maintenance and resulting productivity.

The struggle to implement continuous biomanufacturing at GMP level is slowly advancing.

Lighthouse manufacturing techniques utilize technology and automation to streamline production.

The need for sustainability and early considerations of a lyophilization strategy grow more pertinent on the back of growing biologics volume.

CGTs offer hope for the future of treatments, but the costly manufacturing, slow turnaround time, and need for supplies hinder progress.

The author describes how to seize market opportunities while navigating the requirements of both drug therapies and delivery devices.

Several steps need be taken to achieve lights-out, fully automated operations.

Virtual and augmented reality have emerged as critical digital training tools.